Nurix Therapeutics NRIX
$ 25.04
2.33%
Quarterly report 2024-Q3
added 10-11-2024
Nurix Therapeutics Cash Flow 2011-2024 | NRIX
Annual Cash Flow Nurix Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-81.4 M | -160 M | -84.4 M | -80 K | 601 K | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
7.53 M | 5.35 M | 2.79 M | 2.18 M | 2.35 M | - | - | - | - | - | - | - | - |
Accounts Payables |
6.4 M | 5.06 M | 6.65 M | 3.41 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | 6 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Nurix Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -42 M | - | - | - | -48.5 M | - | -122 M | - | -42.6 M | - | -53.5 M | -23.5 M | 8.05 M | - | 20.4 M | 26.5 M | 41 M | - | 13.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 2.04 M | - | - | - | 1.75 M | - | 1.5 M | 1.3 M | 991 K | - | 700 K | 600 K | 643 K | - | 600 K | 500 K | 491 K | - | 600 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.92 M | 2.81 M | 5.92 M | 6.4 M | 2.19 M | 4.52 M | 5.63 M | 5.06 M | 6.05 M | 6.14 M | 6.01 M | 6.65 M | 3.86 M | 5.4 M | 6.65 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 1.6 M | 1.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | 2 M | - | - | - | - | - | 6 M | 6 M | - | 2.54 M | 6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency